Dr. Sandra Kallert, Cancer Immunology, DBM, University of Basel, Switzerland - Replicating viral vector platform exploits alarmin signals for potent CD8+ T cell-mediated tumor immunotherapy

Speaker: Dr. Sandra Kallert, Cancer Immunology, DBM, University of Basel, Switzerland

Title: Replicating viral vector platform exploits alarmin signals for potent CD8+ T cell-mediated tumor immunotherapy

The seminar takes place Thursday, June 1st, 2017 12:15 - 13:00 at the DBM, Haus Petersplatz, Library - Petersplatz 10